2021

Supreme Court and Judicial Conference Considering Judge Albright’s Problematic Patent Court

The following comes from Chief Justice John Roberts’ end-of-year Report on the Federal Judiciary for 2021.

The third agenda topic I would like to highlight is an arcane but important matter of judicial administration: judicial assignment and venue for patent cases in federal trial court. Senators from both sides of the aisle have expressed concern that case assignment procedures allowing the party filing a case to select a division of a district court might, in effect, enable the plaintiff to select a particular judge to hear a case. Two important and sometimes competing values are at issue. First, the Judicial Conference has long supported the random assignment of cases and fostered the role of district judges as generalists capable of handling the full range of legal issues. But the Conference is also mindful that Congress has intentionally shaped the lower courts into districts and divisions codified by law so that litigants are served by federal judges tied to their communities. Reconciling these values is important to public confidence in the courts, and I have asked the Director of the Administrative Office, who serves as Secretary of the Judicial Conference, to put the issue before the Conference. The Committee on Court Administration and Case Management is reviewing this matter and will report back to the full Conference. This issue of judicial administration provides another good example of a matter that self-governing bodies of judges from the front lines are in the best position to study and solve—and to work in partnership with Congress in the event change in the law is necessary.

https://www.supremecourt.gov/publicinfo/year-end/2021year-endreport.pdf

 

Patently-O Bits and Bytes by Juvan Bonni

Recent Headlines in the IP World:

Commentary and Journal Articles:

New Job Postings on Patently-O:

Update on Supreme Court Patent Cases: Fact Law Divide

by Dennis Crouch

Olaf Sööt Design’s pending petition for certiorari centers on the age-old division between issues-of-fact and issues-of-law.  The U.S. Constitution generally requires due process, and particularly protects litigants’ rights to a jury trial in common law cases.  One quirk–the right to a trial by jury does not cover issues-of-law, and only extends to some issues-of-fact.

This bifurcated system results in an odd dynamic in patent law — regularly seen with regard to infringement and claim construction:

  • Patent infringement is an issue-of-fact tried by a jury under the Seventh Amendment.  Typically, a jury is asked to decide whether the evidence shows that the defendant is performing the claimed invention.
  • Claim construction is treated as a question of law (or mixed question of fact and law), decided by a judge.  In contemporary patent litigation, a judge will typically be asked to decide whether the legal scope of the claims extend to cover the defendant’s actions.

With this setup, the whole case can be decided at either stage, but claim construction typically comes first and so often steals-the-show.  One problem though, is the potential of unduly undermining the Constitutionally protected jury system.

One case pending before the Supreme Court focuses-in on these issues: Olaf Sööt Design, LLC v. Daktronics, Inc., et al., No. 21-438 (Petition).  Sööt asks the following question:

In Markman v. Westview Instruments, Inc., 517 US 370 (1996), this Court held that the meaning of terms in a patent “claim” stands as a question of law and must be construed by the court. Under the Seventh Amendment, if requested by the patent owner, the jury must make the factual determination as to whether the defendant infringed the patent in light of the court’s claim construction. Consistent with the Seventh Amendment, the Markman decision leaves to the jury all factual determinations beyond the court’s construction of the claim. The question presented by this petition for writ of
certiorari is:

Whether the Seventh Amendment allows the Federal Circuit to reverse a jury verdict based on a sua sponte new claim construction of a term the district court concluded was not a term of art and construed to have its plain and ordinary meaning; where the Federal Circuit’s sua sponte claim construction essentially recasts a specific infringement factual question,  previously decided by the jury, as a claim construction issue, to be decided de novo by the appellate court.

The Supreme Court will consider the petition next week.

Patent Law at the Supreme Court December 2021

Merry Christmas 2021, your Patent is Invalid

by Dennis Crouch

Bankers’ Serv. Corp. v. Landis Christmas Sav Club Co, 273 F. 722 (3d Cir. 1921) [67_F.2d_904]

This 1921 decision centered on Merrill B. Barkley US Pat. No. 1,202,646, covering stationary for making “Christmas club deposits.”  The specification explains:

There has developed recently in banking circles a wide demand for various kinds of special savings accounts, known generally as Christmas clubs, vacation accounts … and the like.

The claimed invention then is directed to a “deposit book,” with each page having a stub and detachable coupon.  The customers keep the book with all the stubs showing deposits while the coupon goes to the bank to help direct the deposit.

Landis Christmas Sav Club was already selling supplies to banks, but Barkley was able to improve the system.  In particular, with the Landis system, the a book of coupons was held by the bank, and individual sheets given out to the customer with each deposit.  The Barkley reversal allowed the customer to keep the book and give deposit slips to the bank.  Apparently Landis then copied the Barkley approach and an infringement suit followed.  In essence, Barkley’s device is a reversal of the Landis approach.   And, the appellate court recognized that the Barkley approach was and improvement that “could be more easily and conveniently handled.”

Despite the improvement, the courts found that they were of the time that would “naturally follow” from the prior art rather than rising to the level of an invention:

[I]t was the to-be-expected result which would naturally follow the study of men familiar with the banking and stationery business, when they set themselves to study and improve the Christmas Club system, as all bank employees would do. When such a new system was used by the thousands of keen minds, when better detail and further efficiency of such system would be the customary result of the experience that came from use, we would expect improvements, and the ideas such as Barkley worked out are, in our judgment, the steps that would naturally follow use. To take the cleverness of an improver and award the monopoly of an invention thereto would, to our minds, make of the patent law a hindrance, not a help, in the evolution of progress.

Invalidity affirmed.

Although the decision is issued prior to Graham v. John Deere, it offers an example of the level of ordinary skill in the art likely made a difference.  The appellate court reflected that bank clerks are generally quite clever and diligent in their pursuit of efficiency.  The court’s suggestion that the ubiquity of the prior art makes it much more likely that an improvement will naturally follow.  This last bit on ubiquity is not typically used in the obviousness analysis anymore, but it does appear in Alice, step 2.

At the Drop-Bottom: Sanford v. Kepner, 344 U.S. 13 (1952). 

I previously wrote about the most cited Supreme Court patent cases since 1952.  Today, I’ll write about the least-cited decision: Sanford v. Kepner, 344 U.S. 13 (1952).

Kepner filed his patent application in 1943 and Sanford filed his in 1945 — both directed to drop-bottom rail cars used in mining.

The USPTO interference sided with the first-filer Kepner and so Sanford took the case to Federal Court.  Sanford argued (1) that Sanford should have priority as the first-to-invent and thus get the patent; and (2) even if Kepner gets priority, Kepner’s patent should still be invalidated based upon the prior art.   (“Void for lack of invention.”) The Pennsylvania district court sided with the first-filer Kepner on priority grounds, and refused to decide the question of patentability. Sanford v. Kepner, 99 F. Supp. 221, 222 (M.D. Pa. 1951).   On appeal, Sanford argued that the district court should have decided the validity question also, but the appellate court affirmed. Sanford v. Kepner, 195 F.2d 387, 390 (3d Cir. 1952).  In particular, the 3rd Circuit explained that once the priority issues are decided, the plaintiff would need some additional justification to maintain standing: “some manifest threat … or interference with the activities of the petitioner beyond the issuance of a patent to another is required to create a controversy justiciable under the Declaratory Judgment Act.”  Id.   The Supreme Court then took up the case and again affirmed, with Justice Black writing a short opinion for a unanimous court. Sanford v. Kepner, 344 U.S. 13 (1952).

In its decision, the court noted that the odd setup would likely result in a weak validity challenge:

There would be no attack on the patent comparable to that of an infringement action. Here. the very person who claimed an invention now asks to prove that Kepner’s similar device was no invention at all because of patents issued long before either party made claim for his discovery. There is no real issue of invention between the parties here and we see no reason to read into the statute a district court’s compulsory duty to adjudicate validity.

Id. Affirmed.

 

 

Most Cited Supreme Court Patent Cases Since 1952

by Dennis Crouch

Lots of the new learning in patent law over the past decade has focused on patent eligibility.  But, none of the eligibility cases (new or old) show up in my list of the most cited Supreme Court cases.

  1. Markman v. Westview Instruments, Inc., 517 U.S. 370 (1996) (claim construction);
  2. Christianson v. Colt Industries Operating Corp., 486 U.S. 800 (1988) (arising under jurisdiction);
  3. eBay Inc. v. MercExchange, L.L.C., 547 U.S. 388 (2006) (injunctive relief in accordance with the principles of equity);
  4. Graham v. John Deere Co. of Kansas City, 383 U.S. 1 (1966) (obviousness);
  5. Zenith Radio Corp. v. Hazeltine Research, Inc., 401 U.S. 321 (1971) (antitrust – patent pools – waiver of defenses);
  6. MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007) (licensee standing for declaratory judgment action);
  7. Blonder-Tongue Laboratories, Inc. v. University of Illinois Foundation, 402 U.S. 313 (1971) (non-mutual issue preclusion in patent cases);
  8. Zenith Radio Corp. v. Hazeltine Research, Inc., 395 U.S. 100 (1969) (antitrust – patent pools);
  9. Holmes Group, Inc. v. Vornado Air Circulation Systems, Inc., 535 U.S. 826 (2002) (arising under jurisdiction – patent assertions in counterclaims, overruled by AIA);
  10. Gunn v. Minton, 568 U.S. 251 (2013) (arising under jurisdiction for patent attorney malpractice);
  11. Warner-Jenkinson Co., Inc. v. Hilton Davis Chemical Co., 520 U.S. 17 (1997) (element-by-element, even for doctrine of equivalents);
  12. Hoffman v. Blaski, 363 U.S. 335 (1960) (change of venue under 1404(a));
  13. College Sav. Bank v. Florida Prepaid Postsecondary Educ. Expense Bd., 527 U.S. 666 (1999) (sovereign immunity for patent infringement);
  14. KSR Intern. Co. v. Teleflex Inc., 550 U.S. 398 (2007) (obviousness); and
  15. Kerotest Mfg. Co. v. C-O-Two Fire Equipment Co., 342 U.S. 180 (1952) (declaratory judgment and district court discretion).

The citation ranking here is based upon the cite by other cases.  If we add in PTAB decisions, Briefs, and Articles, then the top four are KSR, Graham v. Deere, Markman, and Alice Corp.

Most of the cases in this list decide some trans-substantive principle and so are being cited outside of the patent context.  The only core patent cases are Markman, Graham v. Deere, Warner-Jenkinson, and KSR.

 

 

Patently-O Bits and Bytes by Juvan Bonni

Recent Headlines in the IP World:

Commentary and Journal Articles:

New Job Postings on Patently-O:

Three new PPAC Members: Charles Duan, Suzanne Harrison, and Heidi Nebel

The Secretary of Commerce has announced three new members of the USPTO’s  Patent Public Advisory Committee (PPAC): Charles Duan, Suzanne Harrison, and Heidi S. Nebel.  Congratulations! All three of these individuals care deeply about improving the patent system, and now have an official seat at the table.

The PPAC is charged with advising the PTO Director on the “policies, goals, performance, budget, and user fees of the United States Patent and Trademark Office with respect to patents.” 35 U.S.C. 5.

PPAC Members:

  1. Steven Caltrider (Chair) – VP and General Patent Counsel, Eli Lilly and Company;
  2. Tracy-Gene Durkin (Vice Chair) – Director at Sterne Kessler;
  3. Jeffrey Sears – Associate General Counsel and Chief Patent Counsel at Columbia University;
  4. Jeremiah Chan – Director and Associate General Counsel at Meta (FB);
  5. Daniel Brown – Professor at the Segal Design Institute of Northwestern University;
  6. Judge Susan Braden – Former Judge of the Ct. Fed. Claims;
  7. Charles Duan – IP-focused public policy researcher at R Street Institute and formerly with Public Knowledge;
  8. Suzanne Harrison – Percipience LLC (IP Strategy); and
  9. Heidi Nebel – McKee, Voorhees & Sease.

These folks are all charged with receiving public input and using it in the process of building a better patent system.  The next public meeting will be in February 2022.

 United States Intellectual Property Organization (USIPO)

by Dennis Crouch

I have written a handful of posts over the years suggesting a merger of the USPTO and Copyright Office to form a United States Intellectual Property Organization (USIPO).  The current fractured structure means that we lack a coherent administrative approach to treatment of the various IP regimes, even though they obviously overlap in very important ways.  Further, although trade secrets are increasingly important to US industry, no federal agency is providing any oversight or guidance.  The political difficulty here, I believe, is that major copyright industry insiders feel that they have captured the copyright office and so are concerned that a transformation would harm their lobbying position.

Apparently, Sen. Thom Tillis is thinking along these same lines, and has been meeting with industry insiders to see whether there may be a consensus approach.  The proposal may be larger — taking control from the President’s hands and creating a more independent agency.

Is it Time to Eliminate Terminal Disclaimers?

I’m trying an open authorship model for a new short paper asking the question:

Is it Time to Eliminate Terminal Disclaimers?

I just wrote 150 words, and so it is 3% of the way toward a 5,000 word goal.  If we get to 5,000 coherent words, then I’ll make sure it gets published — probably in some fancy law journal.

  • Link to the Document for Editing: https://t.co/DXe82py9Aa
  • If you add enough to be listed as a co-author, please add your name and contact info to FN 1.  (Anonymous contributions are also permitted).

Thanks!

 

 

Qatent – AI Generated Applications

I love this project that has the AI tech develop a detailed 20-30 page specification based upon a few claims and short description.  https://information.patentepi.org/issue-2-2021/natural-language-generation-and-patents-be-ready.html

I expect that most folks won’t be satisfied, but in many cases it might be sufficient. And, if the technology is sufficiently mainstream, it suggests that the patent document actually needs less disclosure.

 

USPTO Delays Voluntary Continuing Legal Education Certification

A requirement for continuing legal education (CLE) is on the horizon for US patent attorneys and patent agents, but that horizon has been pushed back once again. The first proposed step was a voluntary certification of CLE attendance. However, Dir. Hirshfeld and OED Dir. Will Covey have pushed that back indefinitely:

On June 10, 2021, the USPTO issued a Federal Register Notice announcing that the voluntary CLE certification would commence in the spring of 2022 but that implementation of the biennial electronic registration statement would be delayed until November 1, 2024. 86 FR 30920.

At this time, based on operational priorities, implementation of the voluntary CLE certification will be delayed indefinitely. The expected implementation date for the biennial electronic registration statement remains November 1, 2024.

Till then, keep reading Patently-O.

No more Paper Patents

US courts formerly tossed around the derogatory term “paper patents” in reference to inventions that were thought experiment scribbled down on paper and never actually reduced to practice.  Ordinarily, paper patents were given more narrow construction than their more well rounded cousins.  But, at least they were still on-paper.

The USPTO has announced its intent to stop printing patent documents on paper as a matter of course.  Rather, the patent grant will remain in electronic storage.  Paper versions will still be printable on-demand — informally from the website or formally with a fee.

This is a good move.

Read more and provide comments here:

  • https://www.federalregister.gov/documents/2021/12/15/2021-27117/electronic-patent-issuance
  • Dir. Blog

Update: Others have noted that USPTO computer servers went down for several hours on the day of this announcement.

 

 

 

PTAB fills-out diaper patent decision: written description and indefiniteness

by Dennis Crouch

Ex parte The Procter & Gamble Co., Appeal 2021-002928, APN. 16/388,898 (PTAB 2021) [2021002928_Mail_Decision]

The PTAB recently issued an odd opinion in this case focusing on the written description requirement.  The application is directed to a “package of absorbent articles.” I.e., a bag full of diapers.  These particular diapers are designed to include a higher percentage of “bio-based materials” and fewer petrochemicals. As such, the claims require that the bag contain “a plurality of absorbent articles … wherein the absorbent articles are devoid of lotion, fragrance or perfume, chlorine, and green number 7 dye.”

The patent examiner rejected the claims as obvious based upon several prior art references.  Those rejections were affirmed by the PTAB, but then the PTAB also added two new grounds of rejections: Indefiniteness and Failure of Written Description.   Basically, the PTAB was concerned with the claim limitation that the diapers are “devoid of … green number 7 dye.”

Appellant’s Specification is silent as to what, exactly, “green number 7 dye” is, or what “undesirable” materials or features it possesses that might warrant its absence from absorbent articles. . . . Further, there is no indication that “green number 7 dye” is a well-known dye, that it has a certain meaning in the industry, or that it falls within any of a number of classifications or descriptions by which dyes are often characterized.

In addition, the specification provided no criteria for determining why “green number 7 dye” is “undesirable.”  Based upon those perceived failures in the specification, the PTAB concluded that “the term ‘green number 7 dye’ … lacks adequate written description support and is indefinite.” Although I have no experience in this area, I did do a 2 minute Google search and found that Green No. 7 is a term of art for Phthalocyanine Green G.

Question: Did the applicant err by not including a better definition of Green No. 7 and by particularly explaining why it is undesirable? The decision here has clear errors, but it does beg the question of the extent that a patent specification needs to explain “why” the inventor made certain choices.  P&G sells diapers both with and without Green No. 7, and I expect that its reasoning is simply that some customers will pay more for the version without.

What Level of Abstraction?

“An abstract idea can generally be described at different levels of abstraction.” Apple, Inc. v. Ameranth, Inc., 842 F.3d 1229, 1240 (Fed. Cir. 2016).

I really have no idea what to make of this quote from Judge Reyna’s opinion, but the PTAB Judges Appear to love it.  More than 600 PTAB decisions have included the full quote over the past few years.   The citation appears to come into play in two occasion: (1) when the PTAB makes a slight shift from what the examiner identified as the relevant abstract idea; and (2) when the claims appear to be directed to something very specific, but that still fails the Alice test.

In general, if the PTAB quotes Ameranth, it finds the claims abstract. Out of 100 recent PTAB eligibility decisions quoting Ameranth, only 1 sided with the applicant on eligibility grounds.

Patent Law at the Supreme Court December 2021

by Dennis Crouch

The Supreme Court has not yet granted a writ of certiorari in any patent cases this term, and has denied certiorari in several dozen cases.  A handful of important petitions are pending whose outcome could be transformative to the law.

Eligibility: American Axle & Manufacturing, Inc. v. Neapco Holdings LLC, No. 20-891. The Federal Circuit concluded that American Axle’s  vehicle-manufacturing claims are ineligible under the two-part tests of Alice and Mayo.  U.S. Patent No. 7,774,911 (Claim 22). The claims here are directed to a method of manufacturing an automobile drive-shaft with reduced vibration.  The basic idea is to insert a liner into a hollow shaft.  The liner though is special — it is made of a “reactive absorber” and its mass and stiffness have been “tuned” all for the purpose of attenuating both “shell mode vibrations” and “bending mode vibrations” of the shaft.  The petition asks two questions:

  1. What does it mean to be “directed to” an ineligible concept? (Alice Step 1).
  2. Is eligibility a pure questions of law (based upon the claims); or is it a “question of fact for the jury based upon the state of the art at the time of the patent?”

The Federal Circuit released a first opinion in the case followed by a toned-down second opinion.  Both opinions were opposed by Judge Moore who explained that even the second try was an “unprecedented expansion of § 101.”  The en banc petition failed, but in a 6-6 tie.  The petition includes several features making certiorari more likely: Issue of historic interest to the Supreme Court; Divided lower court; Multiple amici in support of hearing the case; Multiple similar petitions in other cases; and Prior statement from US Gov’t (Trump Admin) that the Post-Alice eligibility setup needs recalibration.  The Court has also shown signs of interest, including an order for responsive briefing from Neapco, and a request for the views of the Solicitor General (CVSG).  We are now awaiting those views, and I expect that the SG’s brief will give us the best clue as to the likely outcome.  The Supreme Court requested briefing almost 8 months ago – on May 3, 2021. The five most recent CVSG briefs took an average of 5.5 months from the request to the brief. So, we’re at the extreme end of the scale for this one.

There are two other eligibility cases pending: Yanbin Yu, et al. v. Apple Inc., No. 21-811; and WhitServe LLC v. Dropbox, Inc., No. 21-812.  Neither of these are likely to garner interest.

PTAB Practice: The Supreme Court has shown extensive interest in various aspects of AIA Trials.  The top pending case in this area is Mylan v. Janssen.  Mylan filed an IPR petition that was denied based upon the six-factor NHK-Fintiv Rule established under Dir. Iancu. NHK-Fintiv permits the PTAB to deny IPR institution in situations where a parallel district court litigation is already well under way.  Mylan appealed the IPR institution denial, but the Federal Circuit dismissed for lack of appellate jurisdiction, citing 35 U.S.C. § 314(d) (“The determination by the Director whether to institute an inter partes review under this section shall be final and nonappealable.”) In its petition, Mylan asks two questions:

  1. Does 35 U.S.C. § 314(d) categorically preclude appeal of all decisions not to institute inter partes review?
  2. Is the NHK-Fintiv Rule substantively and procedurally unlawful?

Mylan Laboratories Ltd. v. Janssen Pharmaceutica, N.V., No. 21-202.  The petition has received amicus support as has a parallel petition in Apple Inc. v. Optis Cellular Technology, LLC, No. 21-118.  Apple asks whether the law permits either appeal or mandamus in situations where the PTO exceeds its authority in a way that “is arbitrary or capricious, or was adopted without required notice-and-comment rulemaking.”

More Appellate Standing: A third PTAB related appellate standing case is Apple Inc. v. Qualcomm Incorporated, No. 21-746, this one focusing on standing to appeal a final written decision.  The patent act is clear that any “person” other than the patentee can file an IPR petition and, if granted, participate in the trial as a party.  The statute goes on to indicate that “a party dissatisfied with the final written decision” has a right to appeal that decision to the Federal Circuit. 35 U.S.C. 319.   Despite the statutory right to appeal, the Federal Circuit has still refused to hear appeals in situations where the appellant cannot show concrete injury caused by the PTAB decision and redressability of that injury.  The appellate court’s grounding stems from the Constitutional requirement from Article III of an actual case or controversy.

Here, Apple licensed a large number of Qualcomm patents as part of a portfolio license, but has only challenged a couple of them via IPR.  The PTAB sided with Qualcomm and Apple appealed.  On appeal, the Federal Circuit found that Apple had not provided any immediate concrete injury associated with the patent’s existence and so dismissed the appeal. In particular, (1) the court was not shown how the license would change in any way if those patents fell-out; and (2) although the license was set to expire prior to the patents, the court found that potential infringement liability a few years now was too speculative.  Apple has now petitioned for writ of certiorari with the following question: Whether a licensee has Article III standing to challenge the validity of a patent covered by a license agreement that covers multiple patents.  As you can see, this question attempts to tie the case directly to MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007) where the Supreme Court found standing for a licensee to challenge a patent.

Prior Art for IPRs: An interesting statutory interpretation petition was recently filed in Baxter Corporation Englewood v. Beckton, Dickinson and Company, No. 21-819.  Congress was careful to limit the scope of IPR proceedings.  The IPR petition may request claims “only on the basis of prior art consisting of patents or printed publications.”  35 U.S.C. 314(b).  In the case, expert testimony was used to fill a gap in the prior art, and the question is whether the use of expert testimony in this manner violates the statutory provision.

Full Scope Enablement: LDL (“bad cholesterol”) is removed by LDL receptors in the liver.  That’s a good thing. But, the body also makes PCSK9, a protein that can bind to the LDL receptors and destroy them.  Amgen’s solution is an antibody that competitively binds to PCSK9 in a way that prevents them from binding and harming the LDL receptors.  The result then is lowering of LDL in the body.

A monoclonal antibody is a type of protein made up of amino acids.  Amgen’s claims at issue here do not recite the particular amino acid sequence or how the protein is structured and chemically linked.  Rather, the claims are directed to a whole genus of monoclonal antibodies defined by the ability to bind with PCSK9 in a way that blocks PCSK9 from also binding with the LDL receptor.

The jury sided with the patentee on the issue of enablement, but the district court rejected the verdict on renewed JMOL. On appeal, the Federal Circuit sided with the accused infringer — holding that enablement is a question of law, and that the claims were so broad that full-scope-enablement is virtually impossible. In its petition, Amgen argues that (1) enablement should be seen as a question of fact; and (2) that the law does not require “full scope enablement” to the extent demanded by the Federal Circuit here.

A Novel form of Preclusion, the Kessler Doctrine: Finally, we get to res judicata. Lawyers all learned about claim preclusion and issue preclusion. Those two principles of law are designed to ensure finality of judgment and avoid relitigation.  History shows substantial confusion about both terminology and scope, but things have been substantially clear and steady since the adoption of the Restatement (Second) of Judgments in 1982.  One aspect of the historic confusion stems from the Supreme Court’s 1907 decision of Kessler v. EldredKessler has been on a back-burner for decades, but in 2014 the Federal Circuit revived the case and found that it deserved to co-equal — a preclusion doctrine separate and distinct from issue or claim preclusion.  That 2014 Brain Life decision was followed by a further expansion of Kessler in Speedtrack (Fed. Cir. 2015)  and again in PersonalWeb Techs. (2020). 

PersonalWeb’s certiorari petition the Supreme Court asks two questions:

  1. Whether the Federal Circuit correctly interpreted Kessler to create a freestanding preclusion doctrine that [applies] even when claim and issue preclusion do not.
  2. Whether the Federal Circuit properly extended its Kessler doctrine to cases where the prior judgment was a voluntary dismissal.

The Supreme Court has shown interest in the case, and recently called for the Solicitor General to submit a brief on behalf of the U.S. Gov’t.   I have an article on the case coming out in the Akron Law Review that I’ll post in a week or so (after fixing a few citations).

Two More: Although no petitions have been filed yet, the parties in two other cases have  publicly indicated their intent to file petitions by the end of 2021:

  • Intel Corporation v. VLSI Technology LLC (Follow-on case to Mylan v. Janssen and Apple v. Optis); and
  • Ikorongo Texas LLC v. Samsung Electronics Co., Ltd. (proper venue in a situation where the plaintiff holds territorially limited patent right).

See you in January.

Policy Statement on Licensing Negotiations and Remedies for Standards-Essential Patents Subject to F/RAND Commitments

The USPTO has joined forces with the Department of Justice (DOJ) and National Institute of Standards (NIST) in creating a new draft policy statement on licensing of standards-essential patents (SEP) subject to voluntary F/RAND commitments.  The draft seeks further public comments.

The 2021 follows a long history of policy discussions on competition implications of patents in the standards market.

In 2013, a statement indicated that an “exclusionary remedy … may be inconsistent with the public interest” for F/RAND licensed patents.   The 2019 statement rejected that approach and instead explained that a F/RAND commitment should not “bar any particular remedy.”  The new proposal reverts back to 2013 and goes further — indicating that a patent holder who commits its patent as part of a standard-setting negotiation is making a promise that “it will not exercise any market power obtained through standardization.”

Opportunistic conduct by SEP holders to obtain, through the threat of exclusion, higher compensation for SEPs than they would have been able to negotiate prior to standardization, can deter investment in and delay introduction of standardized products, raise prices, and ultimately harm consumers and small businesses.

2021 Draft Statement.  At the same time, the new statement also indicates that implementers must also participate in good faith.

Regarding injunctive relief, the 2021 proposal interprets eBay and Federal Circuit holdings as follows:

Where a SEP holder has made a voluntary F/RAND commitment, the eBay factors, including the irreparable harm analysis, balance of harms, and the public interest generally militate against an injunction.

2021 Statement.

Comments due first week of January 2022 via regulation.gov. The agencies propose the following questions to spur comment:

  1. Should the 2019 Policy Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments be revised?
  2. Does the draft revised statement appropriately balance the interests of patent holders and implementers in the voluntary consensus standards process, consistent with the prevailing legal framework for assessing infringement remedies?
  3. Does the draft revised statement address the competition concerns about the potential for extension of market power beyond appropriate patent scope identified in the July 9, 2021 Executive Order on Promoting Competition in the American Economy?
  4. In your experience, has the possibility of injunctive relief been a significant factor in negotiations over SEPs subject to a voluntary F/RAND commitment? If so, how often have you experienced this?
  5. Are other challenges typically present in negotiating a SEP license? If so, what information should be provided or exchanged as a practical matter to make negotiation more efficient and transparent?
  6. Are small business owners and small inventors impacted by perceived licensing inefficiencies involving SEPs? If so, how can licensing be made more efficient and transparent for small businesses and small inventors that either own, or seek to license, SEPs?
  7. Will the licensing considerations set forth in the draft revised Statement promote a useful framework for good-faith F/RAND licensing negotiations? In what ways could the framework be improved? How can any framework for good-faith negotiations, and this framework in particular, better support the intellectual property rights policies of standards-setting organizations?
  8. What other impacts, if any, would the draft revised statement have on standards-setting organizations and contributors to the standards development process?
  9. The draft revised statement discusses fact patterns intended to indicate when a potential licensee is willing or unwilling to take a F/RAND license. Are there other examples of willingness or unwillingness that should be included in the statement?
  10. Have prior executive branch policy statements on SEPs been used by courts, other authorities, or in licensing negotiations? If so, what effect has the use of those statements had on the licensing process, outcomes, or resolutions?
  11. Are there resources or information that the U.S. government could provide/develop to help inform businesses about licensing SEPs subject to a voluntary F/RAND commitment?

Chinese Firm Banned from USPTO and 15,000 TM cases Terminated

Over the past several years, the USPTO has been battling trademark applications that use fake specimens to establish a claim. Often these are low-quality photoshopped images, but can be more sophisticated.

This week, the UPSTO announced a final order for sanctions against the China-based law firm Shenzhen Huanyee Intellectual Property Co., Ltd. and the firm’s director Ms. Yusha Zhang associated with about 15,000 trademark applications many of which included “false and fraudulent submissions.”

Respondents have engaged in the unauthorized practice of law, provided false domicile information for applicants, impermissibly entered the signature of the named signatory on declarations and verifications, and violated other USPTO Rules and the USPTO’s website terms of use.

The sanctions are quite firm:

  1. Proceedings involving submissions filed by Respondents are terminated (this is about 15,000 TM registration cases, many are already registered others are pending).
  2. Respondents are precluded from further correspondence or submissions.

[Read the order here]

One part of the sanction that folks need to consider has to do with violation of TEAS terms of service and sharing USPTO.GOV accounts.

Respondents registered and shared access to at least three separate uspto.gov accounts including the name of Yusha Zhang. Respondents used these accounts to make submissions on behalf of others through TEAS in thousands of trademark matters. Given that many of the submissions were often filed through TEAS in rapid succession from the various accounts, it is clear that the accounts were used by multiple people, not just Ms. Zhang.

Final order.

Section 1052(c) of the Lanham Act: A First Amendment-Free Zone?

Guest Post by Samuel F. Ernst, Professor of Law, Golden Gate University School of Law.

Can you register a famous person’s name as your trademark without their consent? The Lanham Act seems to say no, and the U.S. Patent and Trademark Office interprets this to mean no, never, no matter what. 15 U.S.C. § 1052(c) provides, in pertinent part, that the PTO must deny federal registration to a trademark if it “[c]onsists of or comprises a name, portrait, or signature identifying a particular individual except by his written consent….” Unlike registration denials under Section 1052(a), the PTO denies registration without any inquiry into whether the mark suggests a false connection between the mark and the famous person. Nor does the PTO inquire into whether the famous person also sells the goods or services in question, as it does with private individuals under Section 1052(c). Rather, with respect to celebrities and world famous political figures, registration is denied based solely on the determinations that (1) “the public would recognize and understand the mark as identifying a particular living individual”; and (2) the record does not contain the famous person’s consent to register the mark.[1] Under this provision, the PTO routinely denies registration to marks that appear calculated to capitalize on the famous person’s name to sell products. For example, the PTO denied registration under Section 1052(c) to ROYAL KATE as applied to watches, cufflinks, jewelry, and other luxury products based solely on the determination that “ROYAL KATE identifies Kate Middleton whose identity is renowned.”[2] Id. And the PTO denied registration to OBAMA PAJAMA in connection with pajamas based on the examining attorney’s “excellent job marshalling a variety of press excerpts to demonstrate the obvious – namely, that President Barack Obama is extremely well known.”[3]

But the PTO also denies registration to marks under this provision even if they constitute political commentary, parody, or other public discourse at the heart of the First Amendment. For example, in 2020 the PTO denied registration to the mark TRUMP TOO SMALL in connection with T-shirts, even though the applicant argued that the mark was “political commentary about presidential candidate and president Donald Trump that the relevant consumer in the United States would not understand to be sponsored by, endorsed by, or affiliated with Donald Trump.”[4] In particular, the mark “is political commentary about [Trump’s] refutation at the March 3, 2016 Republican debate of presidential candidate Marco Rubio’s insinuation that Donald Trump has a small penis”; and “is also political commentary about the smallness of Donald Trump’s overall approach to governing as President of the United States.”[5]  The applicant appealed the PTAB’s denial to the Court of Appeals for the Federal Circuit, which is now deciding whether Section 1052(c) is unconstitutional in violation of the First Amendment,[6] as that court and the Supreme Court have already decided with respect to the provisions in the Lanham Act barring registration of scandalous, immoral, or disparaging marks.[7]

Unlike the bars on registration at issue in Tam and Brunetti, the PTO’s ban on registration under Section 1052(c) does not discriminate against speech based on the viewpoint expressed. Rather, the PTO bars registration whether the mark praises, criticizes, ridicules, parodies, or is neutral toward the famous person. Nonetheless, the bar is a content-based restriction because “its reach is defined simply by the topic (subject matter) of the covered speech”[8] – here, the topic being the famous person in question. And even if viewed as a regulation of purely commercial speech – and therefore not subject to strict scrutiny – the restriction would at least have to pass muster under the Supreme Court’s test in Central Hudson Gas & Electric Corp. v. Public Service Commission, which asks, in pertinent part, whether the regulation burdening speech directly advances a substantial government interest, and whether the regulation “is not more extensive than necessary to serve the interest.”[9] Section 1052(c), at least as broadly interpreted by the PTO, fails this test and is, therefore, unconstitutional.

The PTO’s asserted justification for this total ban on registration is “to protect the intellectual property right of privacy and publicity that a living person has in his/her identity.”[10] Putting aside whether the PTO has a legitimate interest under the Lanham Act in protecting intellectual property rights that are creatures of state law, these justifications plainly fail on their merits.

With respect to the right of privacy, the government does not have a legitimate interest in protecting public figures, such as former President Trump, from speech that criticizes, ridicules, or even praises them. Rather, the First Amendment recognizes “a profound national commitment to the principle that debate on public issues should be uninhibited, robust, and wide-open, and that it may well include vehement, caustic, and sometimes unpleasantly sharp attacks on government and public officials.”[11]

And even if the government has a legitimate interest in guarding the state right of publicity, the Lanham Act’s absolute bar on registering the name of a famous individual absent written consent is far more extensive than necessary to serve that interest. No state recognizes such a sweeping right of publicity that it is subject to zero countervailing First Amendment protections. As Jennifer Rothman observes, “[a]t least five balancing approaches have been applied to evaluate First Amendment defenses in right of publicity cases.”[12]:

  • The Eighth Circuit’s general balancing test, requiring “that state law rights of publicity must be balanced against first amendment considerations.”[13] Under this framework, the Eighth Circuit decided that a fantasy baseball company’s First Amendment right to use the names, statistics, and biographical information of major league baseball players “supersede[d] the players’ rights of publicity.”[14] TRUMP TOO SMALL would pass this test because it is core political speech at the heart of the First Amendment that outweighs any right of publicity.
  • Missouri’s predominant purpose test, which inquires into whether the predominant purpose of using the famous person’s name or identity is to exploit its commercial value; or whether “the predominant purpose of the product is to make an expressive comment on or about a celebrity.”[15] Under this test, the Missouri Supreme Court found that the defendants did not have the First Amendment right to use the name of a famous hockey player as the name of a villain in a comic book because such use was “predominantly a ploy to sell comic books,” and “not a parody or other expressive comment or a fictionalized account.”[16] TRUMP TOO SMALL would pass this test because its predominant purpose is to critique Donald Trump, not to exploit his identity to sell T-shirts.
  • The California test, which borrows from copyright’s fair-use analysis the consideration of “whether the new work merely supersede[s] the objects of the original creation, or instead adds something new, with a further purpose or different character, altering the first with new expression, meaning, or message; it asks, in other words, whether and to what extent the new work is transformative.”[17] Under this test, the court held that the defendant’s free speech rights did not allow him to sell lithographs and T-Shirts with highly realistic depictions of the Three Stooges.[18] TRUMP TOO SMALL would pass this test because Elster’s T-Shirts says more than simply “Trump”; they add the transformative political critique “TOO SMALL” to Trump’s name.
  • An approach adopted by the Third and Ninth Circuits inquiring into whether the use of the plaintiff’s identity was not merely imitative, but rather for purposes of lampoon, parody, caricature, or fanciful and creative, and therefore entitled to First Amendment protection.[19] Under this test, Electronic Arts’ use of images of athletes in video games was too imitative to qualify for First Amendment protection against right of publicity claims.[20] TRUMP TOO SMALL passes this test, because it is for the purpose of lampooning Trump, and does not merely parrot his name standing alone.
  • The test adopted by the Restatement (Third) of Unfair Competition, which allows the use of a person’s identity “in news reporting, commentary, entertainment, works of fiction or nonfiction, or in advertising that is incidental to such uses,” but not “if they are used in advertising the user’s goods or services, or are placed on merchandise marketed by the user, or are used in connection with services rendered by the user.”[21] Under this test, Ginger Rogers and the estate of Fred Astaire could not prevent a filmmaker from using the title “Ginger and Fred” in a fictional film because the use was “clearly related to the content of the movie and is not a disguised advertisement for the sale of goods or services or a collateral commercial product.”[22] TRUMP TOO SMALL passes this test because it is commentary on TRUMP, not a disguised advertisement that is merely incidental to Donald Trump.

Accordingly, the PTO’s absolute ban on the registration of marks such as TRUMP TOO SMALL is far more extensive than necessary to protect the right of publicity, which would not prevent the use of TRUMP TOO SMALL under any state’s right of publicity regime.

These various free speech defenses to the right of publicity have been criticized by scholars for providing an inadequate, misleading patchwork of First Amendment protections.[23] But the PTO’s application of Section 1052(c) is even worse: the PTO takes no countervailing interests into account before denying registration to a mark. The PTO fails to consider: whether registration of the mark would likely cause consumer confusion; whether it would cause dilution of the public figure’s brand; whether the mark suggests a false connection with the person (as separately provided by other provisions); whether there is unjust enrichment or any other type of unfair competition; whether the use of the famous person’s name constitutes news, political commentary, parody, or entertainment speech at the heart of the First Amendment; and indeed without considering any First Amendment defense or legitimate Lanham Act policy whatsoever.

Hence, the PTO’s interpretation of Section1052(c) is a First Amendment-free zone. But what remedy should the Federal Circuit provide? Should the statute be construed so as to require source confusion, dilution, or a false connection with the celebrity before denying registration?[24] Such an interpretation is not plausible because there are separate provisions preventing registration under these circumstances, such that this interpretation would render Section 1052(c) duplicative of Sections 1052(a), (d), and (f).[25] Should the Federal Circuit remand with instructions that the PTO apply one of the First Amendment defenses to the right of publicity detailed above before declining to register a mark, even though those defenses are roundly criticized by scholars?; or perhaps one of the First Amendment defenses that are recommended by scholars?[26] Which one? Is the PTO capable of applying First Amendment balancing tests such as transformative use or fair use in routine registration decisions?; determinations that befuddle and confuse Article III federal courts? Is the PTAB the right body to make such determinations? Do we really want the PTO to be judging distinctions between political speech and purely commercial speech, or might that result in new speech discrimination issues? If the PTO cannot apply a First Amendment test in a reliable, predictable way, must the statute be invalidated because it is impermissibly vague with respect to what speech it burdens?[27]

Or have we gotten this whole question exactly backwards? Perhaps the prohibition on registering famous persons’ names serves in some way to protect political speech. After all, if the PTO registers a mark that is political commentary about a famous person, this gives the registrant certain nationwide rights allowing the registrant to burden other speakers from using the political speech in commerce to the extent it would result in likely confusion. Hence, in some circumstances registration of famous person’s names could perhaps result in less political speech, not more. One thinks of a potential 2024 Marco Rubio presidential campaign that seeks to sell T-Shirts saying TRUMP TOO SMALL, but is burdened by the national registration of that mark by Mr. Elster. As Judge Reyna wrote in dissent in In re Tam, “if the expressive content of the mark precludes regulation, on what authority may the government grant Mr. Tam the exclusive right to use this mark in commerce?”[28] Perhaps the courts should analyze statutes such as this one in the flexible way Justice Breyer suggests in his partial dissent in  Brunetti: by focusing on “the interests the First Amendment protects” and considering whether the harm to those interests is “disproportionate in light of the relevant regulatory objectives.”[29] But these are mere dissents, not the law. The government has not met its burden of advancing such a pro-speech rationale. If protecting political speech were the true government interest behind Section 1052(c), it is a wholly insufficient vehicle for protecting that interest. It is insufficient protection because it still allows the political figure himself to register the political speech including his name, thereby burdening others from using that speech in commerce. Moreover, the PTO can register all kinds of marks that constitute political speech so long as they do not contain the name of a famous person without his consent. The binding precedent of the Federal Circuit and the Supreme Court requires the conclusion that denying the benefits of national registration to marks constituting political speech under these circumstances constitutes an impermissible burden on free speech in violation of the First Amendment.

[1] In re Nieves & Nieves LLC, 113 USPQ2d 1629, 2015 WL 496132, *12 (TTAB 2015).

[2] Id. at *12-*14.

[3] In re Hoefflin, 97 USPQ2d 1176, 2010 WL 5191373, *3 (TTAB 2010).

[4] In re Elster, No. 20-2205, Doc. 43 (Corrected Joint Appendix) at 111 (Response to Office Action of Feb. 19, 2018) (Fed. Cir.) (available on Pacer).

[5] Id.

[6] See In re Elster, No 20-2205 (Fed. Cir.).

[7] See In re Tam, 808 F.3d 1321 (Fed. Cir. 2015) (en banc) (holding that 15 U.S.C. § 1052(a) is unconstitutional with respect to the bar on disparaging marks), aff’d, Matal v. Tam, 137 Sup. Ct.1744 (2017); In re Brunetti, 877 F.3d 1330 (Fed. Cir. 2017) (holding that 15 U.S.C. § 1052(a) is unconstitutional with respect to the bar on immoral and scandalous marks), aff’d, Iancu v. Brunetti, 139 Sup. Ct. 2294 (2019).

[8] In re Tam, 808 F.3d at 1334 (citing Reed v. Town of Gilbert, 135 S.Ct. 2218, 2230 (2015)).

[9] 447 U.S. 557, 566 (1980). See also Matal, 137 Sup. Ct. at 1764 & n. 17 (opinion of Alito, J.) (“[W]e leave open the question whether Central Hudson provides the appropriate test for deciding free speech challenges to provisions of the Lanham Act” because “the disparagement clause cannot withstand even Central Hudson scrutiny”); Brunetti, 139 Sup.Ct. at 2298 (The Court in Tam held that viewpoint discrimination is unconstitutional but “could not agree on the overall framework for deciding the case”); In re Tam, 808 F.3d at 1364-68 (Dyk, J., concurring in part and dissenting in part) (purely commercial speech can be regulated subject to the Central Hudson test).

[10] In re Hoefflin, 2010 WL 5191373, *1.

[11] New York Times Co. v. Sullivan, 376 U.S. 254, 270 (1964).

[12] Jennifer Rothman, The Right of Publicity 145 (Harvard U. Press 2018).

[13] C.B.C. Distribution & Mktg., Inc. v. Major League Baseball Advanced Media, L.P., 505 F.3d 818, 823 (8th Cir. 2007).

[14] Id. at 824.

[15] Doe v. TCI Cablevision, 110 S.W.3d 363, 374 (Mo. 2003) (quoting Mark S. Lee, Agents of Chaos: Judicial Confusion in Defining the Right of Publicity-Free Speech Interface, 23 Loy. L.A. Ent. L. Rev. 471, 500 (2003)).

[16] Id. at 374.

[17] Comedy III Prods., Inc. v. Gary Saderup, Inc., 25 Cal. 4th 387, 404 (2001) (internal citations and quotation marks omitted).

[18] Id. at 409-10.

[19] See, e.g., Davis v. Electronic Arts., 775 F.3d 1172 (9th Cir. 2015).

[20] Id.

[21] Restatement (Third) of Unfair Competition § 47. Rothman refers to this as the “relatedness test.” Rothman, Right of Publicity 146.

[22] Rogers v. Grimaldi, 875 F.2d 994, 1004–05 (2d Cir. 1989).

[23] See, e.g., David Franklyn & Adam Kuhn, Owning Oneself in a World of Others: Towards a Paid-for First Amendment, 49 Wake Forest L. Rev. 977, 1011 (2014) (“The right [of publicity] is growing unchecked, and attempts to balance it against the First Amendment have resulted in a patchwork of misleading potential defenses.”); Rothman, The Right of Publicity at 145 (“The uncertainty of what a speaker can do has itself chilled speech because content creators do not want to risk litigation or liability.”); Stacey L. Dogan & Mark A. Lemley, What the Right of Publicity Can Learn from Trademark Law, 58 Stan. L. Rev. 1161, 1162 (2006) (“[T]he courts have developed no meaningful counterweight to this ever-expanding right [of publicity]. Instead, they have created a few ad hoc exceptions in cases where the sweeping logic of the right of publicity seems to lead to results they consider unfair.”); Eugene Volokh, Freedom of Speech and the Right of Publicity, 40 Hous. L. Rev. 903, 930 (2003) (“[T]here is good reason to think… that the right of publicity is unconstitutional as to all noncommercial speech, and perhaps even as to commercial advertising as well.”)

[24] See Brunetti, 139 Sup.Ct. at 2304 (Breyer, J., concurring in part and dissenting in part) (“Our precedents warn us against interpreting statutes in ways that would likely render them unconstitutional”).

[25] See In re Brunetti, 877 F.3d at 1355 (“It is thus permissible to construe a statute in a manner that preserves its constitutionality only where the construction is reasonable.”); Brunetti, 139 Sup. Ct. at 2302 & note * (declining to narrowly construe the bar on registering scandalous marks to avoid unconstitutionality).

[26] See, e.g., Franklin & Kuhn; Dogan & Lemley, supra note 23.

[27] See In re Tam, 808 F.3d at 1358 (O’Malley, J., concurring) (opining that the disparagement provision of Section 1052(a) should be invalidated because it is impermissibly vague in violation of the Fifth Amendment).

[28] In re Tam, 808 F.3d at 1378 (Reyna, J., dissenting).

[29] Brunetti, 139 Sup.Ct. at 2306 (Breyer, J., concurring in part and dissenting in part).